Neuraxis, Inc. Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc. filed this Form 8-K on September 21, 2023, to announce financial results for the second quarter ended June 30, 2023. The company is incorporated in Delaware and trades on the NYSE American under the symbol NRXS. The filing identifies the company as an emerging growth company.
Financial Results and Key Metrics
The filing states that a press release announcing second-quarter 2023 financial results was furnished as Exhibit 99.1. The filing text provided does not include clear values for revenue, net income or loss, cash flow, margins, debt, cash balances, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior-year or prior-quarter period. Any reported changes would be contained in the referenced press release and investor presentation, which are not included in the supplied text.
Guidance, Outlook, Risks, and Unusual Items
The company furnished an investor presentation as Exhibit 99.2 containing information and financial highlights about the company and its industry. The supplied filing text does not provide clear guidance, forecasts, management commentary, risk updates, contingencies, or unusual items.
The information in Items 2.02 and 7.01, including Exhibits 99.1 and 99.2, was furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Obtain and review Exhibit 99.1 for the complete second-quarter 2023 financial results.
- Review Exhibit 99.2 for management’s investor presentation, operating metrics, outlook, and industry information.
- Verify cash, liquidity, debt, revenue, profitability, cash flow, and margin figures in the underlying financial disclosures.
- Confirm whether the exhibits contain guidance, material risks, contingencies, or non-GAAP measures not reproduced in the Form 8-K text.